{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:19:12Z","timestamp":1787530752114,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2022 Wannan Medical College Talent Introduction Special Fund","award":["YR20230122"],"award-info":[{"award-number":["YR20230122"]}]},{"name":"Scientific Research Project of Anhui Provincial Department of Education","award":["2025AHGXZK31525"],"award-info":[{"award-number":["2025AHGXZK31525"]}]},{"name":"Wannan Medical College horizontal research project","award":["662202404013"],"award-info":[{"award-number":["662202404013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic syndrome (MetS) involves conditions that alter renal structure\/function; however few studies have considered the dynamic nature of metabolic status when exploring its association with chronic kidney disease (CKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively included 7034 participants, categorized into four metabolic phenotypes by BMI and metabolic status: metabolically healthy non-overweight\/obesity (MHNO), metabolically healthy overweight\/obesity (MHO), metabolically unhealthy non-overweight\/obesity (MUNO), and metabolically unhealthy overweight\/obesity (MUO). The primary endpoint was incident CKD (eGFR &lt; 60 ml\/min\/1.73 m\u00b2 and\/or proteinuria for two consecutive years). Associations were assessed using Cox and logistic regression analysis with multivariate adjustments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The baseline proportions of individuals with MHNO, MUNO, MHO, and MUO phenotypes were 35.6%, 17.5%, 18.3%, and 28.6%, respectively. After multivariate adjustment in Cox analyses, MUNO (HR:1.184; 95%CI:1.031-1.506) and MUO (HR:1.420; 95%CI:1.153-1.749) phenotypes were associated with incident CKD, with no such association in the MHO phenotype. However, in terms of transitions, compared with those with a consistent MHNO phenotype, those with a MHO phenotype evolving to a metabolically unhealthy status had higher incident CKD risk (HR:1.649; 95%CI:1.096-2.482).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overweight\/obesity and metabolic unhealthy status increase CKD risk; individuals with MHO who transition to metabolically unhealthy phenotypes have higher CKD risk than those consistently maintaining MHNO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-026-02211-2","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:38:16Z","timestamp":1781545096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between different metabolic phenotypes and chronic kidney disease risk: a cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Qi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"4","key":"2211_CR1","first-page":"315","volume":"13","author":"CD Society","year":"2021","unstructured":"Society CD. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes Mellitus. 2021;13(4):315\u2013409.","journal-title":"Chin J Diabetes Mellitus"},{"issue":"8","key":"2211_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1753944717711379","volume":"11","author":"Y Rochlani","year":"2017","unstructured":"Rochlani Y, et al. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215\u201325.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"3","key":"2211_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/a-1263-0898","volume":"42","author":"A Bovolini","year":"2021","unstructured":"Bovolini A, et al. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int J Sports Med. 2021;42(3):199\u2013214.","journal-title":"Int J Sports Med"},{"issue":"1","key":"2211_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3945\/an.115.010207","volume":"7","author":"CJ Andersen","year":"2016","unstructured":"Andersen CJ, Murphy KE, Fernandez ML. Impact of Obesity and Metabolic Syndrome on Immunity. Adv Nutr. 2016;7(1):66\u201375.","journal-title":"Adv Nutr"},{"issue":"7","key":"2211_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","volume":"8","author":"N Stefan","year":"2020","unstructured":"Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020;8(7):616\u201327.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2211_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","volume":"91","author":"C Garofalo","year":"2017","unstructured":"Garofalo C, et al. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91(5):1224\u201335.","journal-title":"Kidney Int"},{"issue":"10","key":"2211_CR7","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.2215\/CJN.02180311","volume":"6","author":"G Thomas","year":"2011","unstructured":"Thomas G, et al. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6(10):2364\u201373.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"15","key":"2211_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553\u20139.","journal-title":"JAMA"},{"key":"2211_CR9","doi-asserted-by":"publisher","first-page":"1026751","DOI":"10.3389\/fpubh.2022.1026751","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Transition patterns of metabolism-weight phenotypes over time: A longitudinal study using the multistate Markov model in China. Front Public Health. 2022;10:1026751.","journal-title":"Front Public Health"},{"issue":"11","key":"2211_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"12","key":"2211_CR11","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, et al. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022;45(12):3075\u201390.","journal-title":"Diabetes Care"},{"issue":"Suppl","key":"2211_CR12","first-page":"p1","volume":"17","author":"C Chen","year":"2004","unstructured":"Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):p1\u201336.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"2211_CR13","first-page":"245","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases\u2013report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15(3):245\u201352.","journal-title":"Biomed Environ Sci"},{"key":"2211_CR14","doi-asserted-by":"crossref","unstructured":"WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363.","DOI":"10.1016\/S0140-6736(03)15268-3"},{"issue":"12","key":"2211_CR15","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1681\/ASN.2021070988","volume":"32","author":"C Delgado","year":"2021","unstructured":"Delgado C, et al. A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. J Am Soc Nephrol. 2021;32(12):2994\u20133015.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2211_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2215\/CJN.08980914","volume":"10","author":"Y Hashimoto","year":"2015","unstructured":"Hashimoto Y, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10(4):578\u201383.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2211_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12882-022-02858-9","volume":"23","author":"SA Jam","year":"2022","unstructured":"Jam SA, et al. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study. BMC Nephrol. 2022;23(1):233.","journal-title":"BMC Nephrol"},{"issue":"9","key":"2211_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","volume":"6","author":"N Eckel","year":"2018","unstructured":"Eckel N, et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90\u2008257 women (the Nurses\u2019 Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2211_CR19","first-page":"2007","volume":"48","author":"Y Yang","year":"2019","unstructured":"Yang Y. Metabolically Healthy Obesity and Risk of Incident Chronic Kidney Disease in a Korean Cohort Study. Iran J Public Health. 2019;48(11):2007\u201315.","journal-title":"Iran J Public Health"},{"key":"2211_CR20","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher M. Metabolically Healthy Obesity. Endocr Rev. 2020;41(3):bnaa004.","DOI":"10.1210\/endrev\/bnaa004"},{"key":"2211_CR21","doi-asserted-by":"crossref","unstructured":"Cho YK et al. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study. J Clin Endocrinol Metab. 2020;105(3):dgaa033.","DOI":"10.1210\/clinem\/dgaa033"},{"issue":"6","key":"2211_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","volume":"15","author":"JE Hall","year":"2019","unstructured":"Hall JE, et al. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15(6):367\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2211_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ckj\/sfw139","volume":"10","author":"CP Kovesdy","year":"2017","unstructured":"Kovesdy CP. Obesity and kidney disease: hidden consequences of the epidemic. Clin Kidney J. 2017;10(1):1\u20138.","journal-title":"Clin Kidney J"},{"key":"2211_CR24","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.smrv.2020.101337","volume":"53","author":"I Umbro","year":"2020","unstructured":"Umbro I, et al. A systematic review on the association between obstructive sleep apnea and chronic kidney disease. Sleep Med Rev. 2020;53:101337.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"2211_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000494694","volume":"143","author":"E Escasany","year":"2019","unstructured":"Escasany E, Izquierdo-Lahuerta A, Medina-Gomez G. Underlying Mechanisms of Renal Lipotoxicity in Obesity. Nephron. 2019;143(1):28\u201332.","journal-title":"Nephron"},{"key":"2211_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2369-15-122","volume":"15","author":"L Li","year":"2014","unstructured":"Li L, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122.","journal-title":"BMC Nephrol"},{"issue":"3","key":"2211_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1681\/ASN.2020050659","volume":"32","author":"JV Zhao","year":"2021","unstructured":"Zhao JV, Schooling CM. Sex-specific Associations of Sex Hormone Binding Globulin with CKD and Kidney Function: A Univariable and Multivariable Mendelian Randomization Study in the UK Biobank. J Am Soc Nephrol. 2021;32(3):686\u201394.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2211_CR28","first-page":"609","volume":"145","author":"M Martin-Taboada","year":"2021","unstructured":"Martin-Taboada M, Vila-Bedmar R, Medina-G\u00f3mez G. From Obes Chronic Kidney Disease: How Can Adipose Tissue Affect Ren Function? Nephron. 2021;145(6):609\u201313.","journal-title":"From Obes Chronic Kidney Disease: How Can Adipose Tissue Affect Ren Function? Nephron"},{"issue":"6","key":"2211_CR29","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","volume":"13","author":"X Jin","year":"2023","unstructured":"Jin X, et al. Pathophysiology of obesity and its associated diseases. Acta Pharm Sin B. 2023;13(6):2403\u201324.","journal-title":"Acta Pharm Sin B"},{"issue":"21","key":"2211_CR30","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"key":"2211_CR31","doi-asserted-by":"publisher","first-page":"101040","DOI":"10.1016\/j.arr.2020.101040","volume":"59","author":"M Queiroz","year":"2020","unstructured":"Queiroz M, Sena CM. Perivascular adipose tissue in age-related vascular disease. Ageing Res Rev. 2020;59:101040.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2211_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","volume":"19","author":"M Spite","year":"2014","unstructured":"Spite M, Cl\u00e0ria J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014;19(1):21\u201336.","journal-title":"Cell Metab"},{"issue":"2","key":"2211_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2337\/db11-0748","volume":"61","author":"C Koutsari","year":"2012","unstructured":"Koutsari C, et al. Storage rates of circulating free fatty acid into adipose tissue during eating or walking in humans. Diabetes. 2012;61(2):329\u201338.","journal-title":"Diabetes"},{"issue":"1","key":"2211_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","volume":"18","author":"J Baek","year":"2022","unstructured":"Baek J, et al. Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease. Nat Rev Nephrol. 2022;18(1):38\u201355.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"2211_CR35","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/nu11040722","volume":"11","author":"Z Gai","year":"2019","unstructured":"Gai Z, et al. Lipid Accumulation and Chronic Kidney Disease. Nutrients. 2019;11(4):722.","journal-title":"Nutrients"},{"issue":"11","key":"2211_CR36","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.numecd.2020.06.025","volume":"30","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese. Nutr Metab Cardiovasc Dis. 2020;30(11):2017\u201326.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2211_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12882-020-02164-2","volume":"21","author":"S Yu","year":"2020","unstructured":"Yu S, et al. Metabolic healthy obesity is associated with higher incidence of mild decrease estimate glomerular rate in rural northeast Chinese. BMC Nephrol. 2020;21(1):505.","journal-title":"BMC Nephrol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02211-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T23:27:53Z","timestamp":1787527673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02211-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02211-2","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided informed consent, and the study was approved by the Ethics Committee of Yijishan Hospital, Wannan Medical University (Approval Number: 2020-35).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"181"}}